A Clinician's Guide to the Treatment of Endometriosis with Elagolix.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- A Clinician's Guide to the Treatment of Endometriosis with Elagolix.
- Published In:
- Journal of women's health (2002), 30(4), 569-578 (2021)
- Authors:
- Leyland, Nicholas, Estes, Stephanie J, Lessey, Bruce A, Advincula, Arnold P, Taylor, Hugh S
- Database ID:
- RPEP-05541
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-05541APA
Leyland, Nicholas; Estes, Stephanie J; Lessey, Bruce A; Advincula, Arnold P; Taylor, Hugh S. (2021). A Clinician's Guide to the Treatment of Endometriosis with Elagolix.. Journal of women's health (2002), 30(4), 569-578. https://doi.org/10.1089/jwh.2019.8096
MLA
Leyland, Nicholas, et al. "A Clinician's Guide to the Treatment of Endometriosis with Elagolix.." Journal of women's health (2002), 2021. https://doi.org/10.1089/jwh.2019.8096
RethinkPeptides
RethinkPeptides Research Database. "A Clinician's Guide to the Treatment of Endometriosis with E..." RPEP-05541. Retrieved from https://rethinkpeptides.com/research/leyland-2021-a-clinicians-guide-to
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.